NVRS.CN is trading at CA$1.16, up 16%, in a rebound following yesterday's sharp 46.52% drop to CA$1.00. - The company announced on June 29, 2026, it received a notice from the CSE regarding its continued listing requirements. - Noveris Health Sciences must demonstrate compliance by September 30, 2026, to avoid a ".X" inactive designation on its common shares.